"A framework for the optimal design of a minimum set of clinical trials to ..."

B. Taverna et al. (2019)

> Home

Details and statistics

DOI: 10.1016/J.CMPB.2019.104989

access: closed

type: Journal Article

metadata version: 2020-06-15

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cmpb/TavernaCBG19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cmpb/TavernaCBG19
B. Taverna, A. Casonato, Fabrizio Bezzo, Federico Galvanin:
A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease. Comput. Methods Programs Biomed. 179 (2019)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.